Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (SLCTR/2026/019) titled 'Effectiveness and Safety of Intravenous followed by Intranasal Racemic Ketamine in Adults with Treatment-Resistant Depression in Sri Lanka: An Open-Label Single-Arm Pilot Study' on Aug. 1.
Study Type: Interventional
Study Design:
Single arm study
Primary Sponsor: Professor Shehan Williams
Condition:
Treatment Resistant Depression
Intervention:
Intervention (active): Racemic ketamine (ketamine).
This is an open-label, single-arm, uncontrolled pilot study. No control intervention (no placebo/active comparator/standard-therapy control) is planned.
Acute treatment phase (Weeks 1-4):
Drug: Racemic ketamine ...